Correlation Between Elevation Oncology and Icosavax
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Icosavax, you can compare the effects of market volatilities on Elevation Oncology and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Icosavax.
Diversification Opportunities for Elevation Oncology and Icosavax
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Elevation and Icosavax is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Icosavax go up and down completely randomly.
Pair Corralation between Elevation Oncology and Icosavax
If you would invest 61.00 in Elevation Oncology on September 13, 2024 and sell it today you would earn a total of 14.00 from holding Elevation Oncology or generate 22.95% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 1.59% |
Values | Daily Returns |
Elevation Oncology vs. Icosavax
Performance |
Timeline |
Elevation Oncology |
Icosavax |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Elevation Oncology and Icosavax Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Elevation Oncology and Icosavax
The main advantage of trading using opposite Elevation Oncology and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.Elevation Oncology vs. Puma Biotechnology | Elevation Oncology vs. Iovance Biotherapeutics | Elevation Oncology vs. Sarepta Therapeutics | Elevation Oncology vs. Day One Biopharmaceuticals |
Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |